BIO Start-Up Stadium Features Innovation
from Around the World


Congratulations to the 2023 Finalists and Winners! 
Applications for the 2024 Start-Up Stadium will Open in November.


Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology partnering event. During the 2023 BIO International Convention 47 finalists from 12 different countries shared a quick pitch showcasing new technologies and therapeutic solutions to a panel of investor and other expert judges, followed by live feedback. 

Judges evaluated presentations from seed-stage company finalists (less than $1M raised) and from emerging company finalists (more than $1M but less than $10M raised to date), with a winner identified for each category.  Prizes included 'fast-track' admission review to incubator programs such as atThe Innovation Space, for the seed-stage winner, as well as complimentary, one-year memberships in the Biotechnology Innovation Organization with access to the cost-savings programs of BIO Business Solutions, and complimentary registration to the 2024 BIO International Convention in San Diego, California. 

Among a highly innovative and competitive group this year, BIO has compiled all the judges’ feedback and is pleased to announce:

Congratulations to our 2023 Seed-Stage and Emerging Winners
PriZm Therapeutics logo
2023 Seed-Stage Start-Up Winner

PriZm Therapeutics

Chandler, Arizona

Paradox Immunotherapeutics logo
2023 Emerging Start-Up Wiinner

Paradox Immunotherapeutics

Toronto, Ontario, Canada

2023 Seed-Stage Finalists

Company WebsiteMain Therapeutic FocusCompany Location
48Hour DiscoveryPlatform for TherapeuticsCanada
Azora TherapeuticsImmunologyUnited States (California)
ClinialsTools/Drug Development Support TechAustralia
Cyta TherapeuticsMetabolic DiseasesUnited States (Massachusetts)
Delymer TherapeuticsGene/Cell TherapyUnited States (Massachusetts)
Guardian BioOncologyUnited States (Massachusetts)
Mirscience TherapeuticsRegenerative MedicineBrazil
Moleculex co., ltd.InflammationTaiwan
NCMN BioPlatform for TherapeuticsUnited States (Virginia)
PriZm Therapeutics [Winner]Orphan/Rare DiseasesUnited States (Arizona)
ReNewVax LtdVaccinesUnited Kingdom
RT MicroDxDiagnosticsUnited States (Massachusetts)
Saros TherapeuticsOncologyUnited States (Illinois)
StemSightRegenerative MedicineFinland
T-E Meds, Inc.OncologyTaiwan
VaxSyna, Inc.VaccinesUnited States (New Hampshire)

2023 Emerging Start-Up Finalists

Company WebsiteMain Therapeutic FocusCompany Location
AnHorn Medicines Co., Ltd.Platform for TherapeuticsTaiwan
Anticipate BioscienceOncologyUnited States (Arizona)
ARCE TherapeuticsOncologyTaiwan
Ardan PharmaOncologyArgentina
ARIZ Precision MedicineOncologyUnited States (California)
Asgard TherapeuticsOncologySweden
AyuVis Research, Inc.ImmunologyUnited States (Texas)
CorriXR TherapeuticsOncologyUnited States (Delaware)
ElectraTect, Inc.DiagnosticsUnited States (Arizona)
Enquyst Technologies IncTools/Drug Development Support TechUnited States (Massachusetts)
FAKnostics, LLCOncologyUnited States (Arizona)
FELIQS CorporationOphthalmologyJapan
Genius Holdings Co., LtdRespiratoryTaiwan
Gilboa TherapeuticsOncologyIsrael
Grannus Therapeutics, Inc.OncologyUnited States (Indiana)
Immuto ScientificPlatform for TherapeuticsUnited States (Wisconsin)
LASE InnovationTools/Drug Development Support TechUnited States (Massachusetts)
Limax Biosciences, Inc.InflammationUnited States (Massachusetts)
March BiosciencesOncologyUnited States (Texas)
MC SciencesPlatform for TherapeuticsGermany
MelliCell, IncMetabolic DiseasesUnited States (Massachusetts)
Neuroene TherapeuticsCNS/NeurologicalUnited States (District Of Columbia)
OmniCyteOncologyUnited States (Connecticut)
pacDNA TherapeuticsPlatform for TherapeuticsUnited States (Massachusetts)
Paradox Immunotherapeutics [Winner]ImmunologyCanada
Promakhos TherapeuticsInflammationUnited States (Massachusetts)
Reference MedicineDiagnosticsUnited States (Arizona)
ReglageneCNS/NeurologicalUnited States (Arizona)
SwazaRespiratoryUnited States (California)
Zehna Therapeutics IncMetabolic DiseasesUnited States (Ohio)

BIO Thanks the 2023 Participating BIO Start-Up Stadium Judges:

  • Christopher Aleong, Chief Business Officer, Lumosa Therapeutics; Managing Director, BioEngine Capital
  • Gad Berdugo, Managing Partner, Explorium Capital LLC
  • David H. Crean, PhD, Managing General Partner, Cardiff Advisory LLC
  • Kevin Emesiani, PharmD, Senior Associate, Medical Excellence Capital, LLC
  • Bettina Ernst, Director, BERNINA BioInvest
  • Gail Christine Gannon, CEO of Ensanté & Director, Neurotech Collider Lab, UC Berkeley
  • Lu Han, PhD, Partner, Lumira Ventures
  • Mike Huckman, Global Practice Leader, Executive Communications, Real Chemistry
  • Scott M. Kahn, PhD, Founder, Alykomed Global Solutions LLC
  • George MacDougall, Director, Investor Relations & Corporate Communications, Gritstone bio, Inc.
  • Stephanie Marrus, Managing Director of Entrepreneurship, Innovation Ventures, UCSF
  • Anton Neschadim, PhD, Senior Advisor, GreenSky Capital
  • Vinit Nijhawan, Managing Director, MassVentures
  • Younes Ouahid, PhD, Partner, Facultas Partners
  • William D. Provine, PhD, President & CEO, Innovation Space
  • Ryan Roller, Managing Director, Life Science & Healthcare, HSBC
  • Lesley Stolz, PhD, VP, Early Innovation Partnering, Johnson & Johnson Innovation
  • Kitty Wu, PhD, VP, Head of Business Development and Strategy, Fosun Pharma USA
  • Samuel Wu, MD, PhD, Venture Partner, 7G BioVentures
  • John Zhu, PhD, Founder and President, Mayewell Capital
Congratulations to our 2022 Seed-Stage and Emerging Winners
2022 Seed-Stage Start-Up Winner


Los Angeles, California

2022 Emerging Start-Up Winner

SiVEC Biotechnologies

Fort Collins, Colorado

Need Advice on Your Pitch Deck?

Download our pitch presentation guide for additional insight and advice on building a stellar submission,